Publications by authors named "Brenaut E"

Chronic pruritus (CP) is frequent in general medicine and the most common complaint in general dermatology. The prevalence of CP is expected to rise in the future due to the ageing population. The clinical presentation, underlying aetiology and treatment strategy of CP are heterogeneous.

View Article and Find Full Text PDF

Background: Vascular phenotype is associated with a poor prognosis in systemic sclerosis (SSc). The identification of its risk factors could facilitate its early detection.

Objectives: To explore risk factors for a vascular phenotype of SSc, among them a history of pre-eclampsia.

View Article and Find Full Text PDF

Background: The causes of pruritus are multiple and commonly classified into six different categories: dermatological, systemic, neuropathic, psychogenic, mixed and idiopathic. In clinical practice, psychogenic and neurogenic mechanisms tend to be separated in the etiological diagnosis of neuropathic or psychogenic disorders; nevertheless, studies investigating the respective psychogenic and neurogenic components are lacking.

Objective: The main objective of this work was to highlight the differences and potential common characteristics between psychogenic pruritus and neuropathic pruritus.

View Article and Find Full Text PDF

An 18-month-old child presented with persistent pruritus and excoriation involving the right T9 and T10 dermatomes. She did not exhibit any other dermatological or neurological anomalies. Based on magnetic resonance imaging investigation of the spine, T8 ganglioglioma was diagnosed and surgically removed resulting in resolution of the pruritus within a few days.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the effectiveness and safety of the drug omalizumab for treating bullous pemphigoid (BP) in patients who did not respond to standard treatments, analyzing data from 100 patients across 18 medical centers in France from 2014 to 2021.
  • 77% of patients achieved complete remission (CR), and 9% achieved partial remission, with a median time to CR of approximately 3 months, although 14% experienced relapses within a median follow-up of 12 months.
  • Higher baseline levels of anti-BP180-NC16A IgE were linked to better CR outcomes, while other factors like urticarial lesions or eosinophil
View Article and Find Full Text PDF

Background: Pruritus, especially localised to the nostrils, has been reported as a specific sign of brain tumours.

Objectives: The main goal of this study was to estimate the prevalence of pruritus in a group of patients with brain tumours. The second outcome was to better characterise this pruritus with a specific questionnaire and a skin examination.

View Article and Find Full Text PDF

Introduction: Small fiber neuropathies (SFNs) are disorders of skin nerve endings inducing pruritus, burning pain, numbness, and paresthesia. The aims of this study were to search for putative etiologies of SFN and their occurrence in a cohort of patients and to compare patients with SFN to a group of patients without SFN to highlight potential factors associated with SFN.

Methods: This study was observational, retrospective, and monocentric.

View Article and Find Full Text PDF
Article Synopsis
  • Pruritus is a significant symptom of atopic dermatitis (AD), and recent advancements in systemic treatments aim to alleviate this discomfort for patients.
  • A systematic review and meta-analysis examined various topical and systemic treatments for AD, revealing all treatments led to a notable reduction in pruritus, with specific therapies like halometasone and tofacitinib showing the greatest efficacy.
  • The study highlights the rapid expansion of AD treatment options and emphasizes the need to focus on pruritus severity in clinical trials alongside AD assessment.
View Article and Find Full Text PDF

Background And Objectives: Patients frequently complain of mild, transient, unpleasant skin sensations that cannot be diagnosed as common neuropathies. Dermatologists have termed these symptoms "sensitive skin syndrome." This narrative review was performed for a better knowledge by other specialists.

View Article and Find Full Text PDF

Background: Acral pustular disease within the pustular psoriasis/psoriasis-like spectrum mainly includes palmoplantar pustulosis (PPP) and acrodermatitis continua of Hallopeau (ACH). Scarce data argue for a distinction between these two entities, but no study has compared the clinical and epidemiologic characteristics of ACH and PPP.

Objectives: We aimed to perform a comparative description of the epidemiological and clinical characteristics of PPP and ACH in a multicentre retrospective cohort.

View Article and Find Full Text PDF

Cholestatic itch is a disabling symptom that may be secondary to liver or biliary diseases. Management of cholestatic pruritus is complex. A systematic review and meta-analysis on the efficacy of treatments for cholestatic pruritus were performed.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the clinical practice and safety of switching biologics among pediatric psoriasis patients in the BiPe cohort, which included 134 patients.
  • Out of the patients, 29 switched biologics mainly due to loss of efficacy, with most transitions occurring from etanercept to adalimumab or ustekinumab.
  • The research found no significant differences in drug survival rates based on whether the biologics were used as first-line or second-line treatments, indicating a need for more data to guide switching in clinical practice.
View Article and Find Full Text PDF

Objectives: During the COVID-19 pandemic, numerous cases of chilblains have been reported. However, in most cases, RT-PCR or serology did not confirm SARS-CoV-2 infection. Hypotheses have been raised about an interferon-mediated immunological response to SARS-CoV-2, leading to effective clearance of the SARS-CoV-2 without the involvement of humoral immunity.

View Article and Find Full Text PDF

Numerous cases of chilblains have been observed in the course if the COVID-19 pandemic. The aims of this study were to provide comprehensive follow-up data for patients reporting chilblains, and to determine the risk factors for incomplete recovery. Patients referred to 5 hospitals in France between March and May 2020 for chilblains were surveyed on December 2020.

View Article and Find Full Text PDF

Background: The prevalence and impact of pruritus, pain, and other sensory symptoms in skin diseases are poorly known.

Objective: To assess the frequency of these symptoms with dermatoses and their association with depression using data from the "Objectifs Peau" survey.

Methods: A representative sample of 20,012 French individuals was created using the usual quota method.

View Article and Find Full Text PDF

A PHP Error was encountered

Severity: Warning

Message: fopen(/var/lib/php/sessions/ci_session22v42h76eiaimckevlu2js5it8jem3al): Failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 177

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)

Filename: Session/Session.php

Line Number: 137

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once